Ligand validation:4FOA

UFP: 5-FLUORO-2'-DEOXYURIDINE-5'-MONOPHOSPHATE

UFP is a Ligand Of Interest in 4FOA designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4FOA_UFP_B_301	94%	15%	0.076	0.984	2.31	1.62	3	5	0	0	95%	0.9524
4FOA_UFP_C_301	91%	16%	0.082	0.978	2.23	1.65	2	6	1	0	95%	0.9524
4FOA_UFP_A_601	86%	14%	0.096	0.972	2.26	1.75	2	5	2	0	95%	0.9524
4FOA_UFP_D_301	44%	13%	0.199	0.936	2.39	1.72	6	6	0	0	95%	0.9524
4FOG_UFP_A_301	60%	0%	0.149	0.936	5.74	5.23	11	13	6	0	100%	1
5FCT_UFP_A_401	99%	10%	0.055	0.984	2.07	2.45	2	6	7	0	100%	1
3GWC_UFP_E_260	96%	8%	0.071	0.982	1.68	3.15	2	12	2	0	100%	1
1TSN_UFP_A_265	90%	0%	0.088	0.97	5.8	4.22	5	10	4	0	100%	1
1O29_UFP_A_803	85%	7%	0.101	0.967	2.68	2.43	10	13	1	0	100%	1
6ZXO_UFP_E_402	84%	13%	0.121	0.985	2.14	2.01	1	3	2	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.